Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Minoxidil may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
■ ■ ■ ■
Regaine may cause dizziness or low blood pressure. If you experience these side-effects so not drive or operate machinery.
If minoxidil passes into the blood stream it can cause some side-effects related to low blood pressure such as chest pain, rapid heart beat, faintness, dizziness, swollen hands and feet, persistent redness or irritation of the scalp. If you experience any of these side-effects, stop using the medicine and tell your doctor. When Regaine for Women Regular Strength is used as recommended, it is extremely unlikely that these effects will occur. However there is a chance the drug could get into the blood stream if it is over used or if there is a scalp condition such as psoriasis present. Therefore it is very important that you use your medicine as recommended and follow the instructions very carefully. See section 3 ▲ Warning Flammable Liquid. Keep away from heat/sparks/open flames/ hot surfaces – No smoking. Avoid exposure of the container and contents to naked flames during use, storage and disposal. Keep container tightly closed. Store in well-ventilated place. Keep cool. Avoid contact with the eyes, mouth, broken skin and sensitive areas. If the solution is accidentally applied to areas of the body other than the scalp, rinse thoroughly with plenty of water. Do not apply to areas of the body other than the scalp. Exceeding the recommended dose will NOT re-grow your hair any more quickly and you have an increased likelihood of getting side-effects. Accidental ingestion may cause serious cardiac adverse events. Therefore this product has to be kept out of the reach of children. Cases of excessive hair growth on the body of infants have been reported following skin contact with minoxidil application sites of patients (caregivers) using topical minoxidil. Hair growth returned to normal within months when infants were no longer exposed to minoxidil. Care should be taken to ensure that children do not come into contact with areas of your body where you have applied minoxidil topically. Consult a doctor if you notice excessive hair growth on the body of your child during the period you are using topical minoxidil products.
e this medicine This medicine is suitable for most people but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist.
Do not use this medicine… ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■
If you are pregnant or breast-feeding. If you are under the age of 18 or over the age of 65. If you have ever had a bad reaction to minoxidil, ethanol, or propylene glycol. If you are not sure whether your hair loss is hereditary. If you have hair loss caused by drug treatment. If you have total baldness or complete loss of all body hair. If the cause of your hair loss is unknown, is due to childbirth or is sudden and unexpected. If you have high blood pressure, even if it is not being treated. If you have any condition that affects your scalp, including sunburn and psoriasis. If you have a shaved scalp. If you are using creams, ointments or lotions used to treat scalp conditions, e.g. Dithranol – used to treat psoriasis. Tretinoin – used to treat acne or other skin disorders. Corticosteroids – a type of anti-inflammatory Petrolatum – a common ingredient in hair wax or gel. If you have any kind of dressing or bandage on your scalp. Unless you know that your scalp is normal and healthy.
If any of these bullet points apply to you now or in the past, get advice from a doctor or pharmacist before using Regaine for Women Regular Strength.
Talk to your doctor or pharmacist… ■ ■ ■ ■
If you are at all unsure whether your scalp is normal and healthy. If you suffer from heart disease, including abnormal heart rhythms or rates, angina or chest pains and / or circulation disorders. If you are taking or using any other medicines including: certain blood pressure medicines called 'vasodilators' e.g. hydrazaline. There is a potential risk that minoxidil, the active ingredient in Regaine for Women Regular Strength, may interact with these medicines and increase their effect.
■ ■ ■
If you are pregnant or breast-feeding: ■
This product should not be used if you are pregnant or breast-feeding.
Dose
Female Adults aged 18 to 65 years
■ ■
On a completely dry scalp and hair, apply a 1 ml dose to the total affected area twice daily using the best applicator for you. The solution should be massaged lightly into the scalp after application.
Leave at least 12 hours between each use. Do not exceed 2 ml in a day. Do not use more than twice a day.
Continued use of Regaine ■ ■ ■ ■ ■ ■
You may need to use this medicine twice daily for at least 4 months before you see new hair growth, this is because hair growth is a slow process. Hair growth may be soft and downy at the start but should eventually become the same as normal hair. Once the hair has begun to re-grow, you need to continue using this medicine twice a day for the growth to continue. In clinical trials 3 out of every 5 women reported hair re-growth after 8 months of continual use of this product. When you stop using the medicine, the hair that has re-grown may disappear after 3-4 months and the balding / hair loss process will continue. If you have no improvement in your hair growth after one year of use, you should discontinue treatment. If at any time during your treatment you are concerned you should consult your doctor or pharmacist.
Which applicator to use The way you apply the solution to your scalp depends on the amount of baldness / thinning you have and the type of applicator you use (see the options and diagrams following). Choose which option is best for you.
Option 1 – Pump spray Applicator 1. 2. 3.
4.
If you are not sure about the medicine you are taking or using, show the bottle or pack to your pharmacist. If any of these bullet points apply to you now or in the past, talk to a doctor or pharmacist.
Age
5. 6.
This applicator works best for applying the solution to large areas of the scalp. To open bottle: press down on child resistant cap and turn to unscrew it, as per the instructions engraved on the top of the cap. Remove cap and put it to one side. Insert the spray applicator into the bottle and screw on firmly.
After aiming the pump toward the centre of the bald area of the scalp, press the pump once and spread the solution with fingertips to cover all the bald area. Repeat a further 5 times. Avoid breathing spray mist. Remove applicator and place child-resistant-cap back on bottle when not in use. To close the container: screw the cap back into place. The total of 6 sprays will deliver the 1 ml dose of minoxidil that is required. Wash your hands and any other areas other than your scalp which may have come in contact with this medicine.
Option 2 – Extended Spray-tip Applicator 1.
this medicine Regaine for Women Regular Strength is for topical and external use only. It should only be applied directly to the scalp area. ■ ■ ■ ■ ■
Avoid breathing in the spray whilst applying to the scalp. Do not apply to areas of the body other than the scalp. Wash your hands thoroughly before and after applying the solution and rinse other areas that have come into contact with the solution. Make sure your hair and scalp are completely dry before applying the solution. Choose an appropriate applicator to apply the medicine (see 'Which applicator to use?'). Each applicator is designed to accurately release a 1 ml dose when used as described.
Daily dose for Adult Women:
This leaflet was last revised in September 2025
If you accidentally swallow the solution
Regaine is a registered trade mark.
Like all medicines, this medicine can cause side-effects, although not everybody gets them.
FURTHER INFORMATION ABOUT REGAINE FOR WOMEN REGULAR STRENGTH
If you experience any of the following, stop using the medicine and seek immediate medical help: ■ ■
Chest pain. Swelling of the face, lips, mouth, tongue or throat which may cause difficulty in swallowing or breathing.
If you experience any of the following, stop using the medicine and talk to your doctor: ■ ■ ■ ■ ■ ■ ■
Allergic reactions including swollen face, skin redness or itching or throat tightness. Low blood pressure. Fast heart beat or an increased awareness of the heart beat (palpitations). Faintness or dizziness. Swollen hands or feet, shortness of breath. Sudden unexplained weight gain. Persistent local redness or rash.
Q
If my hair growth is restored using Regaine for Women Regular Strength, what will the new hair look like?
A
If you respond to treatment, your initial re-growth may at first be soft, downy ("vellus") hair and may be barely visible. After further treatment, your hair re-growth may change and become the same colour and thickness as the rest of your hair.
Q
Is shampooing necessary before applying Regaine for Women Regular Strength?
A
No, but if you do choose to shampoo, we recommend the use of a shampoo with a gentle cleansing and conditioning action that does not impede the absorption of Regaine for Women Regular Strength.
Q
If I do shampoo, how long must I wait before applying Regaine for Women Regular Strength?
A
To be sure the scalp is thoroughly dry, it is recommended that Regaine for Women Regular Strength be applied one hour after shampooing.
Q
Can I use a hair dryer with Regaine for Women Regular Strength?
Other effects which may occur include
A
Yes, but not to dry the solution itself.
Very common (may affect more than 1 in 10 people)
Q
Can I use common hair styling products such as hair gels or hair sprays while using Regaine for Women Regular Strength?
A
Most hair gels and hair sprays are ok to use with Regaine for Women Regular Strength. However if they contain petrolatum (petroleum jelly) they should not be used. If you do use hair products with Regaine for Women Regular Strength make sure you apply to a dry scalp before applying any other products.
Q
Can I have my hair dyed?
A
Yes, you may; there is no need to change your hair care routine. However, you should tell your hair care professional that you are using Regaine for Women Regular Strength. To minimise breakage of existing hair, just ask that any massaging of your scalp be gentle, and that a comb with widely spaced, round teeth be used to avoid excessive pulling.
Q
Can Regaine for Women Regular Strength be used with a sun-blocking agent?
A
No. if you are planning to be in the sun after applying Regaine for Women Regular Strength, use headwear.
Q
Can I apply Regaine for Women Regular Strength after swimming?
A
Yes, as long as hair is dry. However, Regaine for Women Regular Strength should not be applied more frequently than twice daily.
Q
How long will each bottle of Regaine for Women Regular Strength last?
A
One bottle of Regaine for Women Regular Strength should last for 30 days (one month), if applied twice a day according to directions. As you near the end of a month's supply, you should plan to renew it so that you do not miss a daily application.
Q
Why do boxes always include new applicators? Why not make refills available?
A
Each pack comes with new applicators. So you can be assured that the metering device is always delivering the correct amount of solution and that it has not become clogged of damaged over time.
■
Headache.
Common (may affect up to 1 in 10 people) ■ ■
Itching or dermatitis. Unwanted non-scalp hair has been reported (including facial hair growth in women). Always wash your hands thoroughly after application and if you accidentally apply the solution to parts of your body other than the scalp, rinse thoroughly with plenty of water.
Uncommon (may affect up to 1 in 100 people) ■
Nausea.
Rare (may affect up to 1 in 1,000 people) ■
Change in hair texture may occur. If this happens, you should stop using Regaine.
Other effects which may occur but it is not known how often: ■ ■ ■ ■ ■ ■
■
Depressed mood. Eye irritation. Vomiting Scalp irritation such as local redness, dryness, flaky skin have all been reported. This may be due to propylene glycol in the product. This is usually only a temporary effect, but if it is persistent you should stop using this product. Acne-like rash, itchy rash, blistering, bleeding or ulceration. Temporary hair loss may occur during the first 2-6 weeks of use. This is likely to be as a result of a change within the growth cycle and it should stop within a couple of weeks. If this hair loss continues for longer than 2 weeks, stop using the product and talk to your doctor. Changes in hair colour may occur. If this happens, you should stop using Regaine.
Reporting of side effects If you get any side-effects talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in this leaflet. You can also report side-effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side-effects, you can help provide more information on the safety of this medicine.
The spray pump and the extended spray tip applicator are CE marked components. The manufacturer of these are:
ASM Aerosol-Service AG Industriestrasse 11 CH-4313 Möhlin
CC Chemie GmbH Detmolder Str. 515 DE-33605 Bielefeld
this medicine
This applicator works best for applying the solution to small areas of the scalp, or under hair.
Keep this medicine out of the sight and reach of children. Do not store above 25°C. Do not use this medicine after the expiry date which is stated on the base of the can. The expiry date refers to the last day of that month. 2. 3. 4. 5. 6.
The pump spray applicator must be on the bottle to use the extended tip applicator. Follow steps 2 and 3 for the pump spray applicator first. Then remove small spray head from top of pump spray applicator; fit the extended spray-tip applicator onto the spray shaft and push down firmly. Remove the small cap on the end of the extended tip and put to one side. After aiming the applicator toward the centre of the bald area of the scalp, press the pump once and spread the solution with fingertips to cover all of the bald area. Repeat a further 5 times. Avoid breathing spray mist. Replace the small cap of the extended tip when not in use. To close the container: remove applicator and screw child resistant cap back in place. The total of 6 sprays will deliver the 1 ml dose of minoxidil that is required. Wash your hands and any other areas other than your scalp which may have come in contact with this medicine.
Warning Flammable Liquid. Keep away from heat/sparks/open flames/ hot surfaces – No smoking. Avoid exposure of the container and contents to naked flames during use, storage and disposal. Keep container tightly closed. Store in well-ventilated place. Keep cool. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What this medicine contains The active substance in 1 ml of Regaine for Women Regular Strength is Minoxidil 20 mg.
If anyone uses too much
Other ingredients are: ethanol (alcohol), propylene glycol and water.
Seek immediate medical advice if anyone, including a child, uses too much of this medicine. Take the medicine and container with you.
What the medicine looks like
If you forget to apply a dose of the solution If you miss one or two applications just carry on as normal as if you had not missed the dose – do not use twice as much or twice as often.
Regaine for Women Regular Strength is a solution contained in a 60 ml bottle, enough for 1 month of treatment. Packs contain 1 bottle, a pump spray applicator and spray-tip applicator. The pump spray and extended spray-tip applicators are CE registered components. The legal manufacturer is: ASM, Aerosol-Service AG, Industriestrasse 11, 4313 Möhlin, Switzerland.
If anyone, including a child, swallows any of the solution, take them to a hospital immediately (with Regaine for Women Regular Strength bottle if possible, as the doctor may like to have some idea of how much they have swallowed).
Product Licence holder and Manufacturer: McNeil Products Limited, 50 – 100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK.
The active substance in Regaine for Women Regular Strength is minoxidil.
Medicines with the same active substance, strength and form include: Regaine for Men Extra Strength Scalp Foam 5% w/w Cutaneous Foam (GSL), Regaine for Women Once a Day Scalp Foam 5% w/w Cutaneous Foam. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Regaine for Women Regular Strength, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Regaine for Women Regular Strength is indicated for the treatment of alopecia androgenetica in women aged between 18 and 65.
Onset and degree of hair regrowth may be variable among users. Although trends in the data suggest that those users who are younger, whose hair has been thinning for a shorter period of time or who have a smaller area of thinning on the vertex are more likely to respond to Regaine for Women Regular Strength, individual responses cannot be predicted.
Women aged 18-65:
Hair and scalp should be thoroughly dry prior to topical application of Regaine for Women Regular Strength. A dose of 1 ml Regaine for Women Regular Strength cutaneous solution should be applied to the total affected areas of the scalp twice daily. The total dosage should not exceed 2 ml. If fingertips are used to facilitate drug application, hands should be washed afterwards.
It may take twice daily applications for four months or more before evidence of hair growth can be expected.
If hair re-growth occurs, twice daily applications of Regaine for Women Regular Strength are necessary for continued hair growth. Anecdotal reports indicate that re-grown hair may disappear three to four months after stopping Regaine for Women Regular Strength application and the balding process will continue.
Users should discontinue treatment if there is no improvement after one year.
Special Populations
There are no specific recommendations for use in patients with renal or hepatic impairment
Paediatric and Elderly Populations
Not recommended. The safety and effectiveness of Regaine for Women Regular Strength in children and adolescents below the age of 18 years or adults over the age of 65 years has not been established.
Method of administration
For topical use only.
The method of application varies according to the disposable applicator used:
Pump spray applicator: this is useful for large areas. Aim the pump at the centre of the bald area, press once and spread with fingertips over the entire bald area. Repeat for a total of 6 times to apply a dose of 1 ml. Avoid breathing spray mist.
Extended spray-tip applicator: this is useful for small areas, or under hair. The pump spray applicator must be in place in order to use this additional applicator. Use in the same way as the pump spray.
Regaine for Women Regular Strength is contra-indicated:
- in users with a history of sensitivity to minoxidil, ethanol, or propylene glycol
- in users with treated or untreated hypertension
- in users with any scalp abnormality (including psoriasis and sunburn)
- in users with a shaved scalp
- if occlusive dressings or other topical medical preparations are being used.
Before using Regaine for Women Regular Strength, the user should determine that the scalp is normal and healthy. Topical minoxidil should not be applied to inflamed, infected, irritated or painful scalp skin (see section 4.3).
Topical minoxidil is only indicated for the treatment of alopecia androgenetica and should not be used in other types of hair loss for example when there is no family history of hair loss, hair loss is sudden and/or patchy, hair loss is due to childbirth or the reason for hair loss is unknown.
The patient should stop using Regaine for Women Regular Strength and see a doctor if hypotension is detected or if the patient is experiencing chest pain, rapid heart beat, faintness or dizziness, sudden unexplained weight gain, swollen hands or feet or persistent redness or irritation of the scalp or other unexpected new symptoms occur (see section 4.8).
Patients with known cardiovascular disease or cardiac arrhythmia should contact a physician before using Regaine for Women Regular Strength.
Some patients have experienced changes in hair colour and/or texture with use of Regaine for Women Regular Strength.
Regaine for Women Regular Strength is for external use only. Do not apply to areas of the body other than the scalp.
Using more than the recommended dose or more often will not improve results.
Unwanted hair growth may be caused by the transfer of the product to areas other than the scalp.
Hands should be washed thoroughly after applying the solution. Inhalation of the spray mist should be avoided.
Some consumers reported increased hair shedding upon initiation of therapy with Regaine for Women Regular Strength. This is most likely due to minoxidil's action of shifting hairs from the resting telogen phase to the growing anagen phase (old hairs fall out as new hairs grow in their place). This temporary increase in hair shedding generally occurs two to six weeks after beginning treatment and subsides within a couple of weeks. If shedding persists (>2 weeks), users should stop using Regaine for Women Regular Strength and consult their doctor.
Users should be aware that, whilst extensive use of Regaine for Women Regular Strength has not revealed evidence that sufficient minoxidil is absorbed to have systemic effects, greater absorption because of misuse, individual variability, unusual sensitivity or decreased integrity of the epidermal barrier caused by inflammation or disease processes in the skin (e.g. excoriations of the scalp, or scalp psoriasis) could lead, at least theoretically, to systemic effects.
Accidental ingestion may cause serious cardiac adverse events. Therefore, this product has to be kept out of the reach of children.
This medicine contains 561.07 mg of alcohol (ethanol) in each 1 ml. It may cause burning sensation on damaged skin. Ethanol may cause burning and irritation of the eye. In the event of accidental contact with sensitive surfaces (eye, abraded skin and mucous membranes) the area should be bathed with large amounts of cool tap water.
This medicine contains 200 mg of propylene glycol in each 1 ml and may cause skin irritation.
Patients should be advised to consult their doctor or pharmacist if they are concerned at any time during treatment with Regaine for Women Regular Strength.
Hypertrichosis in children following inadvertent topical exposure to minoxidil:
Cases of hypertrichosis have been reported in infants following skin contact with minoxidil application sites of patients (caregivers) using topical minoxidil. Hypertrichosis was reversible, within months, when infants were no longer exposed to minoxidil. Contact between children and minoxidil application sites should therefore be avoided.
This product should not be used concomitantly with other medications applied topically on the scalp (see section 4.3).
Topical drugs, such as corticosteroids, tretinoin, dithranol or petrolatum, which alter the stratum corneum barrier, could result in increased absorption of minoxidil if applied concurrently. Although it has not been demonstrated clinically, there exists the theoretical possibility of absorbed minoxidil potentiating orthostatic hypotension caused by peripheral vasodilators.
Guanethidine has been reported to interact with oral formulations of minoxidil resulting in rapid and pronounced lowering of blood pressure.
There is a theoretical possibility that topical minoxidil may also interact with guanethidine.
This product should not be used during pregnancy or lactation.
Pregnancy
There are no adequate and well controlled studies in pregnant women. Studies in animals have shown a risk to the foetus at exposure levels that are very high compared to those intended for human exposure. There is potentially a risk of foetal harm in humans (see section 5.3).
Lactation
Systemically absorbed minoxidil is secreted in human milk. The effect of minoxidil on newborns/infants is unknown.
This product may cause dizziness or hypotension (see section 4.8). If affected, patients should not drive or operate machinery.
The safety of topical minoxidil from clinical trial data is based on data from 7 placebo-controlled randomised clinical trials in adults evaluating either 2% or 5% minoxidil solution, and two placebo-controlled randomised clinical trials in adults evaluating a 5% foam formulation.
Adverse drug reactions (ADRs) identified during clinical trials and post-marketing experience with minoxidil are included in the table below by System Organ Class (SOC).
The frequencies are provided according to the following convention:
Very common ≥1/10
Common ≥1/100 and < 1/10
Uncommon ≥1/1,000 and <1/100
Rare ≥1/10,000 and <1/1,000
Very rare <1/10,000, including isolated reports
Not known (cannot be estimated from the available data)
ADRs are presented by frequency category based on 1) incidence in adequately designed clinical trials or epidemiology studies, if available, or 2) when incidence cannot be estimated, frequency category is listed as 'Not known'.
Body System (SOC)
Frequency
Adverse Drug Reaction (Preferred Term)
Immune System Disorders
Common
Hypersensitivity reactions (including face oedema, generalised erythema, pruritus generalised, swelling face, and throat tightness)
Not known
Angioedema (including lip oedema, lip swelling, oedema mouth, oropharyngeal swelling, pharyngeal oedema, swollen tongue and tongue oedema)
Psychiatric Disorders
Not known
Depressed mood
Nervous System Disorders
Very common
Headache
Uncommon
Dizziness
Eye disorders
Not known
Eye irritation
Cardiac disorders
Common
Chest pain
Uncommon
Palpitations
Not known
Heart rate increased
Vascular disorders
Not known
Hypotension
Respiratory, thoracic and mediastinal disorders
Uncommon
Dyspnoea
Gastrointestinal Disorders
Uncommon
Nausea
Not known
Vomiting
Skin and subcutaneous tissue disorders
Common
Hypertrichosis (unwanted non-scalp hair including facial hair growth in women)
Pruritus (including rash pruritic generalised and eye pruritus)
Rash (including pustular, papular, generalised, vestibular and macular rash)
Dermatitis (including contact, allergic, atopic and seborrhoeic dermatitis)
Rare
Changes in hair texture
Not known
Dry skin Skin exfoliation (including exfoliative rash and dermatitis exfoliative)
Acne (acneiform rash)
Temporary hair loss (see section 4.4)
Changes in hair colour
General disorders and administration site conditions
Common
Oedema peripheral
Not known
Application site reactions (These sometimes involve nearby structures like the ears and face and typically consist of pruritus, irritation, pain, rash, oedema, dry skin, erythema and rash erythematous but can sometimes be more severe and include exfoliation, dermatitis, blistering, bleeding and ulceration)
Investigations
Common
Weight increased
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Increased systemic absorption of minoxidil may potentially occur if higher-than-recommended doses of Regaine for Women Regular Strength are applied to larger surface areas of the body or areas other than the scalp.
Because of the concentration of minoxidil in Regaine for Women Regular Strength, accidental ingestion has the potential of producing systemic effects related to the pharmacological action of the drug (5 ml of Regaine for Women Regular Strength contains 100 mg minoxidil; the maximum recommended adult dose for oral minoxidil administration in the treatment of hypertension). Signs and symptoms of minoxidil overdosage would primarily be cardiovascular effects associated with sodium and water retention. Tachycardia, hypotension, dizziness and lethargy can also occur.
Treatment
Treatment of minoxidil overdosage should be symptomatic and supportive.
Fluid retention can be managed with appropriate diuretic therapy. Clinically significant tachycardia can be controlled by administration of a beta-adrenergic blocking agent.
Ask anything about Regaine for Women Regular Strength. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.